Humoral and T-cell-mediated responses to a pre-clinical Zika vaccine candidate that utilizes a unique insect-specific flavivirus platform
D. L. Porier, A. Adam, L. Kang, P. Michalak, J. Tupik, M. A. Santos, C. Lee, I. C. Allen, T. Wang, A. J. Auguste
This study evaluates immune responses to an ISFV-based Zika vaccine, showing neutralizing antibodies and T-cells contribute to protection.
bioRxiv · Mar 1, 2023 · PreprintMicrobiology